TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

GVB Biopharma
Acquired by 22nd Century (Nasdaq: XXII)

As a contract development and manufacturing organization (CDMO), GVB is believed to be one of the largest providers of hemp-derived active ingredients for the pharmaceutical and consumer goods industries worldwide based on total tonnage. GVB is at the vanguard of the organic cultivation, research, development, and marketing of hemp-based wellness solutions for suppliers, customers, and consumers around the globe. Due to GVB’s lower cost technology, it has become a market leading source of CBD active ingredients and private label manufacturing for retailers and marketers. GVB believes it possesses low-cost custom infrastructure and durable competitive technological advantages that have allowed it to scale quickly.

More Like This

Jan 2024

Acquired by Hayden Creek Capital

Exclusive Financial Advisor

View Details >
Aug 2023

InProduction, Inc., a portfolio company of Dubin Clark & Company, has been acquired by ZMC

Exclusive Financial Advisor

View Details >
Jun 2023

Sale of Daleville Production Brewery and Four Corners Brewing Company to New Belgium Brewing Company, Inc. and Founders

Financial Advisor

View Details >